CNS Drugs Journal Issues Research Articles in September 2022 Edition
September 16, 2022
September 16, 2022
CHAM, Switzerland, Sept. 16 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its September 2022 edition:
Review Articles:
* New Oral Drugs for Migraine
* Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Deli . . .
Review Articles:
* New Oral Drugs for Migraine
* Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Deli . . .